ID: ALA5266469

Max Phase: Preclinical

Molecular Formula: C14H9FN2O2S

Molecular Weight: 288.30

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1nccs1)c1ccc(-c2cccc(F)c2)o1

Standard InChI:  InChI=1S/C14H9FN2O2S/c15-10-3-1-2-9(8-10)11-4-5-12(19-11)13(18)17-14-16-6-7-20-14/h1-8H,(H,16,17,18)

Standard InChI Key:  CDNMVOFPVRHMEU-UHFFFAOYSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 288.30Molecular Weight (Monoisotopic): 288.0369AlogP: 3.79#Rotatable Bonds: 3
Polar Surface Area: 55.13Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.99CX Basic pKa: CX LogP: 3.18CX LogD: 3.18
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.80Np Likeness Score: -2.46

References

1. He M, Li YJ, Shao J, Li YS, Cui ZN..  (2023)  Synthesis and biological evaluation of 2,5-disubstituted furan derivatives containing 1,3-thiazole moiety as potential α-glucosidase inhibitors.,  83  [PMID:36764471] [10.1016/j.bmcl.2023.129173]

Source